|
|
||||||||
J Thorac Cardiovasc Surg 2006;131:190-197
© 2006 The American Association for Thoracic Surgery
Surgery for Congenital Heart Disease |
a Department of Pediatrics (Division of Cardiology), Cincinnati Children's Hospital Medical Center and the University of Cincinnati College of Medicine, Cincinnati, Ohio
b Department of Pediatrics (Division of Neurology), Cincinnati Children's Hospital Medical Center and the University of Cincinnati College of Medicine, Cincinnati, Ohio
c Department of Pediatrics (Division of Epidemiology/Biostatistics), Cincinnati Children's Hospital Medical Center and the University of Cincinnati College of Medicine, Cincinnati, Ohio
d Department of Surgery (Division of Cardiothoracic Surgery), Cincinnati Children's Hospital Medical Center and the University of Cincinnati College of Medicine, Cincinnati, Ohio
e Department of Radiology, Cincinnati Children's Hospital Medical Center and the University of Cincinnati College of Medicine, Cincinnati, Ohio
f Department of Anesthesiology, Cincinnati Children's Hospital Medical Center and the University of Cincinnati College of Medicine, Cincinnati, Ohio.
Received for publication June 14, 2005; revisions received July 19, 2005; accepted for publication August 29, 2005. * Address for reprints: Catherine Dent, MD, Cincinnati Children's Hospital Medical Center, 3333 Burnet Ave, MLC 2003, Cincinnati, OH 45229-3039. (Email: catherine.dent{at}cchmc.org).
| Abstract |
|---|
|
|
|---|
METHODS: Twenty-two term neonates with hypoplastic left heart syndrome were studied with brain magnetic resonance imaging before and at a median of 9.5 days after the Norwood operation. Results were compared with preoperative, intraoperative, and postoperative risk factors to identify predictors of neurologic injury.
RESULTS: Preoperative magnetic resonance imaging (n = 22) demonstrated ischemic lesions in 23% of patients. Postoperative magnetic resonance imaging (n = 15) demonstrated new or worsened ischemic lesions in 73% of patients, with periventricular leukomalacia and focal ischemic lesions occurring most commonly. Prolonged low postoperative cerebral oximetry (<45% for >180 minutes) was associated with the development of new or worsened ischemia on postoperative magnetic resonance imaging (P = .029).
CONCLUSIONS: Ischemic lesions occur commonly in neonates with hypoplastic left heart syndrome before surgery. Despite the adoption of regional cerebral perfusion, postoperative cerebral ischemic lesions are frequent, occurring in the majority of infants after the Norwood operation. Long-term follow-up is necessary to assess the functional impact of these lesions.
| Introduction |
|---|
|
|
|---|
|
Neurologic and developmental abnormalities are common in children with hypoplastic left heart syndrome (HLHS) after the Norwood procedure.
1-5
Although the cause of brain injury in these infants is likely multifactorial with contributions from preoperative, intraoperative, and postoperative events, the use of deep hypothermic circulatory arrest (DHCA) seems to play a role in poor neurologic and developmental outcome.
6-10
Ischemic brain lesions have been documented on pathologic brain specimens
11
and on magnetic resonance imaging (MRI)
12
in neonates after surgical palliation in which DHCA is used.
Because of these concerns, many centers have adopted the technique of regional low-flow cerebral perfusion (RLFP) during the aortic arch reconstruction in lieu of DHCA. RLFP decreases the period of cerebral ischemia by limiting decreases in cerebral blood volume and oxygen saturation.
13
Although RLFP has been associated with better neurologic outcome in animal models,
14
such studies have not been performed in humans. In the present study, we compare preoperative and postoperative brain MRI findings in neonates undergoing the Norwood procedure using RLFP.
| Patients and Methods |
|---|
|
|
|---|
36 weeks) and an intention to undergo surgical intervention (Norwood operation with aortic arch reconstruction) using RLFP. Infants were excluded if they had a (1) history of birth asphyxia (5-minute Apgar score <5), (2) genetic anomaly associated with neurodevelopmental abnormalities, or (3) preoperative cardiac arrest. MRI scans of the brain were performed preoperatively (day of surgery) and in the early postoperative period. The scans were performed on a Signa LX 1.5-T scanner (GE Medical, Milwaukee, Wis). The following sequences were performed: (1) sagittal T1-weighted spin-echo images, (2) axial T1-weighted inversion-recovery images, (3) axial and coronal T2-weighted fast spin-echo images, (4) axial diffusion-weighted images, and (5) short echo proton magnetic resonance spectroscopy in the basal ganglia. All MRI scans were reviewed by a single neuroradiologist blinded to the subjects' clinical status. MRI scans were reviewed for congenital and acquired lesions including general or focal atrophy, periventricular leukomalacia (PVL), cerebral edema, delayed myelination, intraparenchymal hemorrhage, intraventricular hemorrhage, and infarct. All lesions were classified as mild, moderate, or severe. PVL, infarction, and intraparenchymal hemorrhage were considered to represent ischemia.
| Clinical Management |
|---|
|
|
|---|
For the preoperative MRI, anesthesia was induced with fentanyl (5 µg/kg), midazolam (0.1 mg/kg), and vecuronium (0.2 mg/kg). In patients not already mechanically ventilated, nasotracheal intubation was performed. Patients were monitored during the MRI with continuous pulse oximetry, capnography, electrocardiography, and blood pressure measurements. After the MRI, patients were transported to the operating suite for cardiac surgery. Surgical repair consisted of aortic arch reconstruction, ascending aortapulmonary artery anastomosis, and creation of an unrestrictive atrial septal communication. Pulmonary blood flow was provided by either a systemicpulmonary artery shunt or a right ventriclepulmonary artery conduit.
Cardiopulmonary bypass (CPB) and surgical management followed our usual institutional practice. Whole blood was added to the primer to yield a goal hematocrit of 28% to 30% during CPB. Arterial blood gaspH management followed the
-stat strategy on CPB initiation with switch to pH-stat strategy during cooling. The
-stat strategy was resumed during rewarming. All patients were cooled to deep hypothermia (18°C). During reconstruction of the aortic arch, continuous RLFP was provided through the innominate shunt at 30 mL · kg · min. Before separation from CPB, patients received a loading dose of milrinone (37.5 µg/kg). Dopamine and epinephrine infusions were instituted and titrated to achieve adequate blood pressure and systemic vascular resistance.
Postoperative management was provided in the CICU. Inotropic medication was adjusted at the discretion of the attending physician. Sodium nitroprusside was added as tolerated for afterload reduction and to improve cardiac output. Management targets included mean arterial pressure of 45 mm Hg or greater, mixed venous oxygen saturation (SvO 2) 50% or greater, arterial oxygen saturation (SaO 2) 70% or greater, and hematocrit greater than 40%. Blood for SvO 2 measurement was sampled from a catheter placed intraoperatively in the superior vena cava. SvO 2 was measured on admission and every 4 hours. Cerebral rSO 2 monitoring continued for 48 hours after surgery. Postoperative inotrope scores were calculated every 6 hours.
The postoperative MRI was performed when the patients were deemed suitable for transport, generally between 5 and 14 days after surgery. Sedation was provided with oral pentobarbital (5 mg/kg) in spontaneously breathing patients and with inhaled anesthesia in intubated patients. Patients were monitored in similar fashion as with the preoperative scan. Postoperative EEG and neurologic examination by a pediatric neurologist were performed when the patient was no longer receiving sedation.
| Data Collection and Statistical Analysis |
|---|
|
|
|---|
Distributions of variables were examined for normality, and appropriate adjustments were performed by using variance stabilizing transformations or nonparametric analyses, when necessary. Associations between the outcome variables and various risk factors were analyzed using Fisher exact tests for categorical outcome and risk factor variables, Student t tests and logistic regression for binary outcomes, and linear regression for continuous variables. Analysis was performed with SAS statistical software (SAS Institute, Cary, NC).
| Results |
|---|
|
|
|---|
|
|
| Neurologic Evaluation and Magnetic Resonance Imaging Results |
|---|
|
|
|---|
|
Postoperative Studies
Table 4
summarizes postoperative study results. Of the 21 patients who underwent surgery using RLFP, postoperative MRI was performed in 15 patients. Five patients died early after surgery, and MRI was deferred in 1 patient because of the need for cardiac pacing. The median duration between surgery and postoperative MRI was 9.5 days (range 4-112 days). Two patients had follow-up MRI performed more than 3 weeks after surgery because of clinical instability.
|
New or worsened ischemic lesions were observed in 11 (73%) of 15 patients. These lesions included PVL in 7 patients (47%) and focal ischemic or hemorrhagic-ischemic lesions in 8 patients (53%). The PVL occurred primarily in the frontoparietal region and occurred bilaterally in 6 of the 7 patients (Figure 1). All patients with preoperative ischemia had new or worsened lesions on postoperative study. Mild extra-axial (subdural or choroid plexus) or intraventricular hemorrhage not requiring intervention was observed in 7 patients (47%). One patient had significant hemorrhage into an area of ischemia in the left frontal area (seen preoperatively), which was surgically drained (Figure 2). Magnetic resonance spectroscopy demonstrated lactate elevation in 3 of the 15 patients, all with ischemic lesions on MRI. Eight of 11 patients with conventional BT shunt (73%) and 3 of 4 patients with right ventriclepulmonary artery conduits (75%) had new or worsened ischemia on postoperative MRI.
|
|
| Risk Factor Analysis |
|---|
|
|
|---|
Analysis of risk factors for the presence of new or worsened area of ischemia on postoperative MRI demonstrated a significant association between prolonged postoperative low rSO 2 (>180 cumulative minutes with rSO 2 < 45%) and the development of MRI lesions (Fisher exact test, P = .029). Sensitivity and specificity were calculated at 82% and 75%, respectively, with a positive predictive value of 90% and a negative predictive value of 60%. The nadir of rSO 2, indirect measures of cardiac output such as SvO 2, and inotrope scores in the postoperative period were not related to the development of lesions. Similarly, intraoperative variables including type of pulmonary blood flow (BT shunt or right ventriclepulmonary artery conduit) and durations of CPB and RLFP did not relate to the development of MRI ischemic lesions. Patients with evidence of preoperative ischemia were more likely to have new postoperative ischemia (P = .08), but this did not reach statistical significance.
| Discussion |
|---|
|
|
|---|
Risk factors for preoperative ischemia have not been well defined. In our study, although peak preoperative base deficit, one indicator of tissue perfusion, was associated with the presence of preoperative ischemia, other postnatal clinical indicators of overall cardiac output (eg, pH and serum lactate) were not associated with lesions on preoperative MRI. Our study also demonstrates that preoperative rSO
2 is not associated with preoperative MRI ischemic lesions. A possible explanation for this finding is that cerebral ischemia occurred before the time period of near-infrared spectroscopy monitoring, either in utero or after birth but before the monitoring period. Although our near-infrared spectroscopy monitoring did not encompass the entire preoperative time period, no patient had a significant change in hemodynamics or SaO
2 during the preoperative period, so the measurements obtained during our monitoring period are likely to be representative of the entire preoperative state. Nevertheless, because rSO
2 measurements are being performed in a small (regional) area of the brain, they may not be a global representation of cerebral perfusion or may miss areas of regional ischemia, and may therefore be falsely reassuring. A recent study found that low cerebral blood flow is common in patients with congenital heart disease and is associated with MRI findings of PVL.
18
There is also evidence that ischemia may occur in these infants in utero. Abnormalities in cerebral vascular blood flow dynamics have been found in fetuses with HLHS, similar to those seen with other forms of fetal hypoxia.
19,20
In contrast with a previous study
21
that demonstrated very low preoperative cerebral rSO
2 in patients with HLHS, our study found cerebral desaturation to be relatively uncommon in our preoperative patients, with only 4 of the 22 patients having any preoperative rSO
2 less than 45% and only 2 patients with more than 30 minutes with rSO
2 less than 45%. All 4 of these patients had normal preoperative MRI findings.
Postoperative Findings
Despite modification in surgical technique using RLFP, new or worsened ischemic brain lesions occurred in the majority (73%) of our patients after the Norwood procedure, with an incidence similar to that seen with DHCA.
12
Prolonged low rSO
2 (>180 minutes with rSO
2
45%) was associated with the presence of lesions on postoperative MRI. Intraoperative factors such as CPB and RLFP time were not associated with MRI lesions, nor were indirect measures of overall cardiac output such as SvO
2, serum lactate, or acid-base status. These data are interesting for 2 reasons. First, they suggest that the postoperative period rather than the intraoperative period may now be the critical period during which neurologic injury occurs or progresses. Second, they suggest that the usual clinical measurements followed in the CICU to assess global cardiac output may not reflect cerebral perfusion, particularly in the early postoperative period, perhaps because of loss of cerebral autoregulation.
The modification of the Norwood procedure to adopt the use of RLFP has been made in many centers to avoid longer periods of DHCA. The association of longer periods of DHCA with impaired neurologic outcome has been well documented,
1,7,8,22,23
but until recently, DHCA has been believed to be a necessary component of arch reconstruction. RLFP limits the period of cerebral ischemia, improves cerebral oxygenation, and has been shown to be associated with better neurologic outcome in piglets.
14
It is unknown, however, whether RLFP is associated with better neurologic outcome after the Norwood procedure. Our study demonstrates that ischemic lesions on MRI are no less frequent in patients who underwent surgery with RLFP versus those who underwent surgery with DHCA.
12
Hoffman and colleagues
24
have noted that although RLFP provides consistent brain perfusion associated with high rSO
2, cerebral desaturation occurs rapidly on removal from CPB. Furthermore, they noted that cerebral rSO
2 decreased to much lower levels after CPB than somatic rSO
2 (measured in the splanchnic bed), suggesting that cerebral vascular resistance is higher than somatic resistance in this time period. We noted an identical rapid decrease in cerebral rSO
2 in our patients after separation from CPB, which persisted in the early postoperative period.
Animal models of cerebral hypoxia-ischemia have demonstrated an association between low rSO
2 and neuronal dysfunction, cell death, and poor neurologic outcome. In a piglet model of graded hypoxia-ischemia to determine thresholds for neurologic injury, brain tissue lactate accumulation began when rSO
2 decreased to less than 45%.
25
Our findings suggest that the rSO
2 threshold for neuronal injury is similar in neonates and that maneuvers to improve cerebral perfusion during the postoperative period may lessen the incidence of postoperative ischemia. There are both animal and human data associating low rSO
2 and neurologic outcome.
26,27
The clinical relevance of our MRI findings is unknown. In the preterm neonate, however, MRI findings of PVL have been associated with long-term neurocognitive impairment, including visuospatial and visuomotor abnormalities, attention deficit disorders, and developmental delay.
28,29
Given the frequency of neurodevelopmental abnormalities in patients with HLHS, it seems likely that these lesions are clinically relevant as well.
| Limitations |
|---|
|
|
|---|
| Conclusions |
|---|
|
|
|---|
We are indebted to our nurse coordinators, Tracey VanVliet, RN, Teresa Barnard, RN, and Lois Bogenschutz, RN, for their tireless assistance.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
J. A. Ballweg, R. F. Ittenbach, J. Bernbaum, M. Gerdes, T. E. Dominguez, E. H. Zackai, R. R. Clancy, and J. W. Gaynor Hyperglycaemia after Stage I palliation does not adversely affect neurodevelopmental outcome at 1 year of age in patients with single-ventricle physiology Eur. J. Cardiothorac. Surg., October 1, 2009; 36(4): 688 - 693. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Chen and A. J. Parry The current role of hybrid procedures in the stage 1 palliation of patients with hypoplastic left heart syndrome Eur. J. Cardiothorac. Surg., July 1, 2009; 36(1): 77 - 83. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. G. Ohye, C. S. Goldberg, J. Donohue, J. C. Hirsch, M. Gaies, M. L. Jacobs, J. G. Gurney, and Michigan Congenital Heart Outcomes Research and Di The quest to optimize neurodevelopmental outcomes in neonatal arch reconstruction: The perfusion techniques we use and why we believe in them J. Thorac. Cardiovasc. Surg., April 1, 2009; 137(4): 803 - 806. [Full Text] [PDF] |
||||
![]() |
A. Szwast, Z. Tian, M. McCann, D. Donaghue, and J. Rychik Right Ventricular Performance in the Fetus With Hypoplastic Left Heart Syndrome Ann. Thorac. Surg., April 1, 2009; 87(4): 1214 - 1219. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. S. McQuillen Magnetic Resonance Imaging in Congenital Heart Disease: What to Do With What We See and Don't See? Circulation, February 10, 2009; 119(5): 660 - 662. [Full Text] [PDF] |
||||
![]() |
J. C. Hirsch, J. R. Charpie, R. G. Ohye, and J. G. Gurney Near-infrared spectroscopy: What we know and what we need to know--A systematic review of the congenital heart disease literature J. Thorac. Cardiovasc. Surg., January 1, 2009; 137(1): 154 - 159. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Li, G. Zhang, H. Holtby, B. Bissonnette, G. Wang, A. N. Redington, and G. S. Van Arsdell Carbon dioxide-a complex gas in a complex circulation: Its effects on systemic hemodynamics and oxygen transport, cerebral, and splanchnic circulation in neonates after the Norwood procedure. J. Thorac. Cardiovasc. Surg., November 1, 2008; 136(5): 1207 - 1214. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Tabbutt, A. S. Nord, G. P. Jarvik, J. Bernbaum, G. Wernovsky, M. Gerdes, E. Zackai, R. R. Clancy, S. C. Nicolson, T. L. Spray, et al. Neurodevelopmental Outcomes After Staged Palliation for Hypoplastic Left Heart Syndrome Pediatrics, March 1, 2008; 121(3): 476 - 483. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Newburger, R. A. Jonas, J. Soul, B. D. Kussman, D. C. Bellinger, P. C. Laussen, R. Robertson, J. E. Mayer Jr, P. J. del Nido, E. A. Bacha, et al. Randomized trial of hematocrit 25% versus 35% during hypothermic cardiopulmonary bypass in infant heart surgery J. Thorac. Cardiovasc. Surg., February 1, 2008; 135(2): 347 - 354. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Li, G. Zhang, H. Holtby, A.-M. Guerguerian, S. Cai, T. Humpl, C. A. Caldarone, A. N. Redington, and G. S. Van Arsdell The influence of systemic hemodynamics and oxygen transport on cerebral oxygen saturation in neonates after the Norwood procedure J. Thorac. Cardiovasc. Surg., January 1, 2008; 135(1): 83 - 90. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. P Miller and P. S McQuillen Neurology of congenital heart disease: insight from brain imaging Arch. Dis. Child. Fetal Neonatal Ed., November 1, 2007; 92(6): F435 - F437. [Full Text] [PDF] |
||||
![]() |
C. S. Goldberg, E. L. Bove, E. J. Devaney, E. Mollen, E. Schwartz, S. Tindall, C. Nowak, J. Charpie, M. B. Brown, T. J. Kulik, et al. A randomized clinical trial of regional cerebral perfusion versus deep hypothermic circulatory arrest: Outcomes for infants with functional single ventricle J. Thorac. Cardiovasc. Surg., April 1, 2007; 133(4): 880 - 887. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. D. Williams and C. Ramamoorthy Brain monitoring and protection during pediatric cardiac surgery. Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 2007; 11(1): 23 - 33. [Abstract] [PDF] |
||||
![]() |
S. D. Markowitz, R. N. Ichord, G. Wernovsky, J. W. Gaynor, and S. C. Nicolson Surrogate markers for neurological outcome in children after deep hypothermic circulatory arrest. Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 2007; 11(1): 59 - 65. [Abstract] [PDF] |
||||
![]() |
B. D. Kussman, K. Gauvreau, J. A. DiNardo, J. W. Newburger, A. S. Mackie, K. L. Booth, P. J. del Nido, S. J. Roth, and P. C. Laussen Cerebral perfusion and oxygenation after the Norwood procedure: Comparison of right ventricle-pulmonary artery conduit with modified Blalock-Taussig shunt J. Thorac. Cardiovasc. Surg., March 1, 2007; 133(3): 648 - 655. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. S. McQuillen, A. J. Barkovich, S. E.G. Hamrick, M. Perez, P. Ward, D. V. Glidden, A. Azakie, T. Karl, and S. P. Miller Temporal and Anatomic Risk Profile of Brain Injury With Neonatal Repair of Congenital Heart Defects Stroke, February 1, 2007; 38(2): 736 - 741. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. J. Visconti, D. Rimmer, K. Gauvreau, P. del Nido, J. E. Mayer Jr, I. Hagino, and F. A. Pigula Regional Low-Flow Perfusion Versus Circulatory Arrest in Neonates: One-Year Neurodevelopmental Outcome Ann. Thorac. Surg., December 1, 2006; 82(6): 2207 - 2213. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Hannan, M. A. Ybarra, J. W. Ojito, F. A. Alonso, A. F. Rossi, and R. P. Burke Complex Neonatal Single Ventricle Palliation Using Antegrade Cerebral Perfusion. Ann. Thorac. Surg., October 1, 2006; 82(4): 1278 - 1285. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Hoffman Neurologic Monitoring on Cardiopulmonary Bypass: What Are We Obligated to Do? Ann. Thorac. Surg., June 1, 2006; 81(6): S2373 - S2380. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |